As Risperdal Goes Generic, Antipsychotics Seek To Differentiate Themselves

Johnson & Johnson and other manufacturers of atypical antipsychotics face erosion of their market share with FDA's approval of the first generic version of J&J's Risperdal (risperidone). But they may ward off competition by emphasizing the differences between their products and the first generic among the newer antipsychotics